Ascendis Pharma Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Revenue	368.7	363.64	266.72	51.17	7.78	6.95	Upgrade
Revenue Growth (YoY)	12.06%	36.34%	421.20%	557.93%	11.87%	-48.02%	Upgrade
Cost of Revenue	54.21	44.26	44.4	12.14	3.52	-	Upgrade
Gross Profit	314.5	319.38	222.32	39.04	4.26	6.95	Upgrade
Selling, General & Admin	325.41	291.14	264.41	221.23	160.18	76.67	Upgrade
Research & Development	322.92	307	413.45	379.62	295.87	260.9	Upgrade
Operating Expenses	648.33	598.15	677.86	600.85	456.05	337.57	Upgrade
Operating Income	-333.83	-278.76	-455.54	-561.81	-451.79	-330.62	Upgrade
Interest Expense	-33.13	-65.5	-44.07	-30.68	-3.91	-1.92	Upgrade
Interest & Investment Income	39.64	14.36	16.86	7.43	0.69	1.81	Upgrade
Earnings From Equity Investments	12.32	-20.06	-18.4	-17.7	12.04	-9.52	Upgrade
Currency Exchange Gain (Loss)	-27.15	-27.15	12.35	40.43	59.03	-78.92	Upgrade
Other Non Operating Income (Expenses)	3.87	3.87	14.65	-15.48	-	-	Upgrade
Pretax Income	-338.28	-373.24	-474.14	-577.82	-383.94	-419.17	Upgrade
Income Tax Expense	3.4	4.84	7.3	5.38	-0.37	-0.22	Upgrade
Net Income	-341.68	-378.08	-481.45	-583.19	-383.58	-418.96	Upgrade
Net Income to Common	-341.68	-378.08	-481.45	-583.19	-383.58	-418.96	Upgrade
Shares Outstanding (Basic)	59	58	56	56	55	51	Upgrade
Shares Outstanding (Diluted)	59	58	56	56	55	51	Upgrade
Shares Change (YoY)	3.88%	2.85%	0.38%	2.37%	8.21%	8.84%	Upgrade
EPS (Basic)	-5.82	-6.53	-8.55	-10.40	-7.00	-8.28	Upgrade
EPS (Diluted)	-5.82	-6.53	-8.55	-10.40	-7.00	-8.28	Upgrade
Free Cash Flow	-220.86	-307.62	-469.8	-510.19	-441.35	-291.41	Upgrade
Free Cash Flow Per Share	-3.76	-5.31	-8.35	-9.10	-8.06	-5.76	Upgrade
Gross Margin	85.30%	87.83%	83.36%	76.28%	54.71%	100.00%	Upgrade
Operating Margin	-90.54%	-76.66%	-170.80%	-1097.85%	-5808.59%	-4755.07%	Upgrade
Profit Margin	-92.67%	-103.97%	-180.51%	-1139.63%	-4931.56%	-6025.53%	Upgrade
Free Cash Flow Margin	-59.90%	-84.60%	-176.14%	-996.97%	-5674.38%	-4191.11%	Upgrade
EBITDA	-328.83	-273.83	-448.99	-544.3	-436.85	-321.17	Upgrade
EBITDA Margin	-89.19%	-75.30%	-168.34%	-	-	-	Upgrade
D&A For EBITDA	5	4.94	6.55	17.51	14.95	9.45	Upgrade
EBIT	-333.83	-278.76	-455.54	-561.81	-451.79	-330.62	Upgrade
EBIT Margin	-90.54%	-76.66%	-170.80%	-	-	-	Upgrade

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q